FTY20D2311: A two-year, double-blind, randomized, multicenter, active-controlled study to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon ?-1a i.m. once weekly in pediatric patien

Project: Research project

Project Details

StatusFinished
Effective start/end date3/11/149/30/17

Funding

  • Novartis Pharmaceuticals Corporation